| |
| |
|
| Insider
Information: |
Sandrock Alfred |
| Relationship: |
President and CEO, Dir... |
| City: |
Weston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
333,008 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,999,262 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
333,008 |
|
|
| Total
Value |
$4,999,262 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -10.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
Head of Research & Dev... |
2021-06-07 |
10,169 |
|
0 |
Premium* |
|
|
Voyager Therapeutics, Inc. |
VYGR |
President and CEO, Dir... |
2024-04-02 |
322,839 |
2022-03-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2015-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,824 |
16,398 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP CMO Neuro & Neurodegenerat |
• • – |
2016-02-12 |
4 |
D |
$247.22 |
$451,671 |
D/D |
(1,827) |
8,712 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Research & Development |
• • – |
2020-02-12 |
4 |
D |
$331.76 |
$630,676 |
D/D |
(1,901) |
13,806 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP CMO Neuro & Neurodegenerat |
• • – |
2017-04-03 |
4 |
AS |
$274.08 |
$542,952 |
D/D |
(1,981) |
7,060 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2014-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,988 |
23,395 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Chief Medical Officer |
• • – |
2018-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,012 |
8,565 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2014-02-11 |
4 |
AS |
$314.31 |
$655,336 |
D/D |
(2,085) |
13,667 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Chief Medical Officer |
• • – |
2019-02-12 |
4 |
D |
$319.43 |
$804,325 |
D/D |
(2,518) |
8,753 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP CMO Neuro & Neurodegenerat |
• • – |
2016-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,799 |
9,085 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2015-03-01 |
4 |
D |
$409.59 |
$1,157,501 |
D/D |
(2,826) |
12,178 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2014-03-03 |
4 |
D |
$340.68 |
$963,784 |
D/D |
(2,829) |
18,578 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2014-03-04 |
4 |
AS |
$342.58 |
$1,086,321 |
D/D |
(3,171) |
15,407 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2015-03-02 |
4 |
AS |
$406.40 |
$1,299,715 |
D/D |
(3,174) |
9,004 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Research & Development |
• • – |
2021-02-12 |
4 |
D |
$278.03 |
$975,885 |
D/D |
(3,510) |
17,738 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Research & Development |
• • – |
2021-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
3,728 |
16,794 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Research & Development |
• • – |
2021-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,454 |
19,715 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Chief Medical Officer |
• • – |
2019-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,643 |
9,452 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Research & Development |
• • – |
2020-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,216 |
14,509 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
President and CEO |
• • – |
2023-04-03 |
4 |
S |
$7.83 |
$58,232 |
D/D |
(7,437) |
214,618 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
Head of Research & Development |
• • – |
2021-06-07 |
4 |
AS |
$440.00 |
$3,375,680 |
D/D |
(7,672) |
10,169 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2014-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,740 |
21,832 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2013-09-16 |
4 |
OE |
$49.65 |
$487,563 |
D/D |
9,820 |
24,320 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Grp SVP, Chief Medical Officer |
• • – |
2013-09-16 |
4 |
AS |
$240.10 |
$2,357,821 |
D/D |
(9,820) |
14,500 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
President and CEO |
• • – |
2024-04-02 |
4 |
S |
$9.86 |
$119,454 |
D/D |
(12,115) |
322,839 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
President and CEO |
• • – |
2024-02-21 |
4 |
S |
$7.46 |
$97,226 |
D/D |
(13,033) |
334,954 |
0 |
% |
|
80 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
